Arylsulfatase A pseudodeficiency and Lafora bodies in a patient with progressive myoclonic epilepsy

Epilepsia. 1994 Mar-Apr;35(2):332-5. doi: 10.1111/j.1528-1157.1994.tb02440.x.

Abstract

Since age 12 years, a 25-year-old woman had a syndrome with myoclonic epilepsy, cerebellar signs, and spontaneous myoclonus. Skin biopsy showed typical Lafora bodies (LB), but she lacked a progressive course and mental impairment, hallmarks of Lafora disease. Lysosomal enzyme assays showed low level arylsulfatase A (ASA) activity. DNA study disclosed a homozygous ASA Pd genotype. Both parents carried one Pd allele. The still-unknown relationship between the pathologic level of ASA activity and myoclonic epilepsies suggests introduction of ASA assays in patients with PME.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Cerebroside-Sulfatase / deficiency*
  • Cerebroside-Sulfatase / genetics
  • Epilepsies, Myoclonic / diagnosis*
  • Epilepsies, Myoclonic / genetics
  • Epilepsies, Myoclonic / pathology
  • Female
  • Genotype
  • Humans
  • Inclusion Bodies / pathology
  • Skin / pathology
  • Sweat Glands / pathology

Substances

  • Cerebroside-Sulfatase